Photo taken from Amer Zeidan/X
Jun 18, 2024, 03:11
Amer Zeidan: Dr. Shahram Kordasti detailing the ‘immunologic mess’ in bone marrow failure conditions
Amer Zeidan shared a post on X:
“Dr. Shahram Kordasti detailing the ‘immunologic mess’ in bone marrow failure conditions & how to target it therapeutically. Dr Kordasti has also been doing an amazing job in leading & organizing collaborative efforts to study, monitor & target immunobiome in Myelodysplastic syndromes (MDSs) through i4MDS group.”
Source: Amer Zeidan/X
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 17:22
Nov 21, 2024, 17:14
Nov 21, 2024, 16:37
Nov 21, 2024, 16:28